- 专利标题： Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions
-
申请号： US17035327申请日： 2020-09-28
-
公开(公告)号： US12103958B2公开(公告)日： 2024-10-01
- 发明人: Natasha Kay Crellin , Lauren Kate Ely , Jason Robles Reyes , Chia Chi Ho , Jeffrey A. Bluestone , Eleonora Trotta , Qizhi Tang
- 申请人： PFIZER INC. , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.,The Regents of the University of California
- 当前专利权人： Pfizer Inc.,The Regents of the University of California
- 当前专利权人地址： US NY New York; US CA Oakland
- 代理机构： Kilpatrick Townsend & Stockton LLP
- 主分类号： C07K14/705
- IPC分类号： C07K14/705 ; A61K39/00 ; C12N15/63 ; G01N33/50 ; G01N33/68
摘要：
The invention provides LFA3 polypeptide molecules, e.g., variant LFA3 fusion polypeptide molecules. The invention includes uses, and associated methods of using the LFA3 polypeptide molecules.
公开/授权文献
- US20210032308A1 LFA3 VARIANTS AND COMPOSITIONS AND USES THEREOF 公开/授权日：2021-02-04
信息查询
